Effect of Rituximab in Primary Central Nervous System Lymphoma - results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study

被引：0
|
作者：
Bromberg, Jacoline
Issa, Samar
Bukanina, Katerina
Minnema, Monique C.
Seute, Tatjana
Durian, Marc
Cull, Gavin
Schouten, Harry C.
Stevens, Wendy B.
Zijlstra, Josee
Baars, Johanna W.
Nijland, Marcel
Mason, Kylie
Beeker, Aart
van den Bent, Martin
de Jong, Daphne
Gonzales, Michael Anthony
Doorduijn, Jeanette K.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
582
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EFFECT OF RITUXIMAB IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA - RESULTS OF THE RANDOMIZED PHASE III HOVON 105/ALLG NHL 24 STUDY
    Bromberg, J. E. C.
    Issa, S.
    Bakunina, K.
    Minnema, M. C.
    Seute, T.
    Cull, G.
    van den Bent, M. J.
    Gonzales, M.
    de Jong, D.
    Doorduijn, J. K.
    NEURO-ONCOLOGY, 2018, 20 : 220 - 220
  • [2] Effect of Rituximab in Primary Central Nervous System Lymphoma-Results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (02) : 16 - 17
  • [3] RITUXIMAB IN PRIMARY CNS LYMPHOMA-LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY
    Bromberg, J. E. C.
    Issa, S.
    van der Holt, B.
    Minnema, M. C.
    Seute, T.
    Durian, M. F.
    Cull, G.
    van der Poel, M. W. M.
    Stevens, W. B. C.
    Zijlstra, J. M.
    Nijland, M.
    Mason, K. D.
    Beeker, A.
    Brandsma, D.
    van den Bent, M. J.
    Gonzalez, M.
    de Jong, D.
    Doorduijn, J. K.
    NEURO-ONCOLOGY, 2022, 24
  • [4] Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
    Bromberg, Jacoline E. C.
    Issa, Samar
    Bakunina, Katerina
    Minnema, Monique C.
    Seute, Tatjana
    Durian, Marc
    Cull, Gavin
    Schouten, Harry C.
    Stevens, Wendy B. C.
    Zijlstra, Josee M.
    Baars, Joke W.
    Nijland, Marcel
    Mason, Kylie D.
    Beeker, Aart
    van den Bent, Martini
    Beijert, Max
    Gonzales, Michael
    de Jong, Daphne
    Doorduijn, Jeanette K.
    LANCET ONCOLOGY, 2019, 20 (02): : 216 - 228
  • [5] Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial
    van der Meulen, Matthijs
    Dirven, Linda
    Habets, Esther J. J.
    Bakunina, Katerina
    Smits, Marion
    Achterberg, Hakim C.
    Seute, Tatjana
    Cull, Gavin
    Schouten, Harry
    Zijlstra, Josee M.
    Brandsma, Dieta
    Enting, Roelien H.
    Beijert, Max
    Taphoorn, Martin J. B.
    van den Bent, Martin J.
    Issa, Samar
    Doorduijn, Jeanette K.
    Bromberg, Jacoline E. C.
    NEURO-ONCOLOGY, 2021, 23 (08) : 1315 - 1326
  • [6] Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study
    Bromberg, Jacoline E. C.
    Issa, Samar
    van der Holt, Bronno
    van der Meulen, Matthijs
    Dirven, Linda
    Minnema, Monique C.
    Seute, Tatjana
    Durian, Marc
    Cull, Gavin
    van der Poel, Marjolein W. M.
    Stevens, Wendy B. C.
    Zijlstra, Josee M.
    Brandsma, Dieta
    Nijland, Marcel
    Mason, Kylie D.
    Beeker, Aart
    Abrahamse-Testroote, Martine C. J.
    van den Bent, Martin J.
    de Jong, Daphne
    Doorduijn, Jeanette K.
    NEURO-ONCOLOGY, 2024, 26 (04) : 724 - 734
  • [7] Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma
    Nayak, Lakshmi
    Abrey, Lauren E.
    Drappatz, Jan
    Gilbert, Mark R.
    Reardon, David A.
    Wen, Patrick Y.
    Prados, Michael
    Deangelis, Lisa M.
    Omuro, Antonio
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 58 - 61
  • [8] The Role of Rituximab in Primary Central Nervous System Lymphoma
    Jacoline E. C. Bromberg
    Matthijs van der Meulen
    Jeanette K. Doorduijn
    Current Oncology Reports, 2020, 22
  • [9] The Role of Rituximab in Primary Central Nervous System Lymphoma
    Bromberg, Jacoline E. C.
    van der Meulen, Matthijs
    Doorduijn, Jeanette K.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (08)
  • [10] Effect of rituximab on primary central nervous system lymphoma: a meta-analysis
    Yue Song
    Yibo Wen
    Weili Xue
    Yanjie Zhang
    Mingzhi Zhang
    International Journal of Hematology, 2017, 106 : 612 - 621
12345